Xenetic Biosciences, Inc. (XBIO) financial statements and ratios from SEC XBRL: revenue $2.98M (TTM), net margin -90.1%, revenue growth 12.0% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $2.98M |
| Net Margin | -90.1% |
| Revenue Growth (YoY) | 12.0% |
| EPS Growth (YoY) | -8.9% |
| Price / Book | 1.35 |
| Price / Sales | 2.52 |
| Altman Z-Score | -28.11 (distress) |
| Sector P/E (Healthcare) | 21.7 |
XBIO overview · XBIO earnings · XBIO KPIs · XBIO investor relations · XBIO ownership · XBIO peers · XBIO filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.